Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?

Heart Rhythm

Volumn 13, Issue 1, 2016, Pages 46-53

  Chao, Tze Fan ^a,b   Liu, Chia Jen ^a,b   Tuan, Ta Chuan ^a,b   Chen, Su Jung ^a,b   Wang, Kang Ling ^a,b   Lin, Yenn Jiang ^a,b   Chang, Shih Lin ^a,b   Lo, Li Wei ^a,b   Hu, Yu Feng ^a,b   Chen, Tzeng Ji ^a   Chiang, Chern En ^a,b   Chen, Shih Ann ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Asians; Atrial fibrilation; CHA2DS2 VASc score; CHADS2 score; Ischemic stroke

Indexed keywords

ACCURACY; AGED; ARTICLE; ASIAN; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CAUCASIAN; CHA2DS2 VASC SCORE; CHADS2 SCORE; CHINESE; COMPARATIVE STUDY; FEMALE; HAZARD RATIO; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; TAIWAN; COMPLICATION; MEASUREMENT ACCURACY; MIDDLE AGED; PROCEDURES; PROGNOSIS; PROPENSITY SCORE; RISK FACTOR; STANDARDS; STATISTICS; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DATA ACCURACY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPENSITY SCORE; RISK ASSESSMENT; RISK FACTORS; STATISTICS AS TOPIC; STROKE; TAIWAN;

EID: 84955504720     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.08.017     Document Type: Article

References (32)

1. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
2. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
3. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation Chest 137 2010 263 272
4. J.B. Olesen, G.Y. Lip, M.L. Hansen, P.R. Hansen, J.S. Tolstrup, J. Lindhardsen, C. Selmer, O. Ahlehoff, A.M. Olsen, G.H. Gislason, and C. Torp-Pedersen Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
5. T.F. Chao, Y.J. Lin, H.M. Tsao, and et al. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation J Am Coll Cardiol 58 2011 2380 2385
6. T.S. Potpara, M.M. Polovina, M.M. Licina, J.M. Marinkovic, M.S. Prostran, and G.Y. Lip Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study Circ Arrhythm Electrophysiol 5 2012 319 326
7. T.F. Chao, C.J. Liu, S.J. Chen, and et al. Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1? Stroke 43 2012 2551 2555
8. A.J. Camm, G.Y. Lip, R. De Caterina, I. Savelieva, D. Atar, S.H. Hohnloser, G. Hindricks, and P. Kirchhof focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
9. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 2014 2246 2280
10. JCS Joint Working Group Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013) Circ J 78 2014 1997 2021
11. A. Verma, J.A. Cairns, L.B. Mitchell, and et al. 2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation Can J Cardiol 30 2014 1114 1130
12. Ogawa S, Aonuma K, Tse HF, Huang D, Huang JL, Kalman J, Kamakura S, Nair M, Shin DG, Stiles M, Teo WS, Yamane T. The APHRS's 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation. J Arrhythm 2013;29:190-200.
13. T.F. Chao, Y.C. Huang, C.J. Liu, and et al. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study Heart Rhythm 11 2014 1941 1947
14. T.F. Chao, C.J. Liu, K.L. Wang, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, T.J. Chen, G.Y. Lip, and S.A. Chen Using the CHA2DS2-VASc score for refining stroke risk stratification in "low-risk" Asian patients with atrial fibrillation J Am Coll Cardiol 64 2014 1658 1665
15. T.F. Chao, C.J. Liu, S.J. Chen, K.L. Wang, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, T.J. Chen, C.E. Chiang, and S.A. Chen Does digoxin increase the risk of ischemic stroke and mortality in atrial fibrillation? A nationwide population-based cohort study Can J Cardiol 30 2014 1190 1195
16. L.J. Lin, M.H. Cheng, C.H. Lee, D.C. Wung, C.L. Cheng, and Y.H. Kao Yang Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation: a nationwide descriptive study in Taiwan Clin Ther 30 2008 1726 1736
17. C.H. Chang, Y.C. Lee, C.T. Tsai, S.N. Chang, Y.H. Chung, M.S. Lin, J.W. Lin, and M.S. Lai Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease Atherosclerosis 232 2014 224 230
18. C.L. Cheng, Y.H. Kao, S.J. Lin, C.H. Lee, and M.L. Lai Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan Pharmacoepidemiol Drug Saf 20 2011 236 242
19. C.Y. Hsieh, C.H. Chen, C.Y. Li, and M.L. Lai Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database J Formos Med Assoc 114 2015 254 259
20. G.Y. Lip, and D.A. Lane Modern management of atrial fibrillation requires initial identification of "low-risk" patients using the CHA2DS2-VASc score, and not focusing on "high-risk" prediction Circ J 78 2014 1843 1845
21. T.P. Van Staa, E. Setakis, G.L. Di Tanna, D.A. Lane, and G.Y. Lip A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice J Thromb Haemost 9 2011 39 48
22. J.B. Olesen, C. Torp-Pedersen, M.L. Hansen, and G.Y. Lip The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study Thromb Haemost 107 2012 1172 1179
23. C.E. Chiang, K.L. Wang, and G.Y. Lip Stroke prevention in atrial fibrillation: an Asian perspective Thromb Haemost 111 2014 789 797
24. T.F. Chao, C.J. Liu, S.J. Chen, K.L. Wang, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, T.J. Chen, H.M. Tsao, and S.A. Chen Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation: could it refine clinical risk stratification in AF? Int J Cardiol 170 2014 344 349
25. C.T. Tsai, S.H. Chang, S.N. Chang, J.J. Hwang, C.K. Wu, Y.C. Wang, C.D. Tseng, H.M. Yeh, L.P. Lai, F.T. Chiang, and J.L. Lin Additive effect of the metabolic syndrome score to the conventional CHADS(2) score for the thromboembolic risk stratification of patients with atrial fibrillation Heart Rhythm 11 2014 352 357
26. J.B. Olesen, G.Y. Lip, A.L. Kamper, K. Hommel, L. Kober, D.A. Lane, J. Lindhardsen, G.H. Gislason, and C. Torp-Pedersen Stroke and bleeding in atrial fibrillation with chronic kidney disease N Engl J Med 367 2012 625 635
27. J.P. Piccini, S.R. Stevens, Y. Chang, and et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts Circulation 127 2013 224 232
28. D.E. Singer, Y. Chang, L.H. Borowsky, M.C. Fang, N.K. Pomernacki, N. Udaltsova, K. Reynolds, and A.S. Go A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score Journal of the American Heart Association 2 2013 e000250
29. A.S. Kim, and S.C. Johnston Global variation in the relative burden of stroke and ischemic heart disease Circulation 124 2011 314 323
30. L.K. Wong Global burden of intracranial atherosclerosis Int J Stroke 1 2006 158 159
31. R.G. Hart, L.A. Pearce, R.M. Rothbart, J.H. McAnulty, R.W. Asinger, and J.L. Halperin Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators J Am Coll Cardiol 35 2000 183 187
32. S.H. Hohnloser, D. Pajitnev, J. Pogue, J.S. Healey, M.A. Pfeffer, S. Yusuf, and S.J. Connolly Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy J Am Coll Cardiol 50 2007 2156 2161